These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1386292)

  • 1. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
    Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF
    Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
    Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A
    Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.
    Koda Y; Nishi S; Suzuki M; Hirasawa Y
    Kidney Int Suppl; 1999 Jul; 71():S251-3. PubMed ID: 10412791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
    Shoji T; Nishizawa Y; Kawagishi T; Kawasaki K; Taniwaki H; Tabata T; Inoue T; Morii H
    J Am Soc Nephrol; 1998 Jul; 9(7):1277-84. PubMed ID: 9644639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
    Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lp(a) and premature mortality during chronic hemodialysis treatment.
    Cressman MD; Abood D; O'Neil J; Hoff HF
    Chem Phys Lipids; 1994 Jan; 67-68():419-27. PubMed ID: 8187242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein Lp(a) in patients with chronic renal insufficiency on hemodialysis].
    Cuxart M; Sans R; Vicente M; Pérez Gallofré A; Masdeu Jufré S; Ponsatí C
    Med Clin (Barc); 1989 May; 92(20):769-71. PubMed ID: 2529402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid parameters including Lp(a) in hemodialysis patients.
    Elisaf M; Bairaktari H; Tzallas C; Germanos N; Koulouridis E; Pappas M; Siamopoulos KC; Tsolas O
    Ren Fail; 1994; 16(4):501-9. PubMed ID: 7938758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.
    Goldwasser P; Michel MA; Collier J; Mittman N; Fein PA; Gusik SA; Avram MM
    Am J Kidney Dis; 1993 Jul; 22(1):215-25. PubMed ID: 8322786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein (a) is a risk factor for cerebrovascular accident in patients with chronic renal failure].
    Ishikawa H
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):846-52. PubMed ID: 8072223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
    Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
    J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis.
    Topciu Shufta V; Begolli L; Kryeziu E
    Bosn J Basic Med Sci; 2010 Feb; 10(1):19-25. PubMed ID: 20192926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial.
    Mirfatahi M; Tabibi H; Nasrollahi A; Hedayati M
    Iran J Kidney Dis; 2016 Nov; 10(6):405-412. PubMed ID: 27904000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between lipoprotein (a) and risk of atherosclerotic cardiovascular disease events among maintenance hemodialysis patients in Beijing, China: a single-center, retrospective study.
    Liang Q; Zhang G; Jiang L
    BMC Nephrol; 2024 Aug; 25(1):250. PubMed ID: 39090533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.